51. THU0049 Development of tfh-th1 like cells through epigenetic modification by stats family factors in patients with systemic lupus erythematosus. (12th June 2018) Authors: Ma, X.; Nakayamada, S.; Kubo, S.; Sakata, K.; Yamagata, K.; Tanaka, Y. Journal: Annals of the rheumatic diseases Issue: Volume 77(2018)Supplement 2 Page Start: 250 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
52. THU0145 A multi-biomarker disease activity (MBDA) score measures rheumatoid arthritis disease activity in patients treated with the JAK inhibitor tofacitinib. (23rd January 2014) Authors: Yamaoka, K.; Kubo, S.; Sonomoto, K.; Hirata, S.; Voinov, A.; Rowe, M.; Cavet, G.; Saito, K.; Tanaka, Y. Journal: Annals of the rheumatic diseases Issue: Volume 71(2012)Supplement 3 Page Start: 204 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
53. THU0203 Baricitinib Targets The Type I IFN/STAT-Medicated Activities of Human T Cells and Dendritic Cells. (15th July 2016) Authors: Kubo, S.; Nakayamada, S.; Nakano, K.; Tanaka, Y. Journal: Annals of the rheumatic diseases Issue: Volume 75(2016)Supplement 2 Page Start: 260 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗